A Study of CDK-002 (exoSTING) in Subjects with | Clinical Research Studies Listing

A Study of CDK-002 (exoSTING) in Subjects with Advanced/Metastatic Recurrent Injectable Solid Tumors with Emphasis on Squamous Cell Carcinoma of the Head and Neck Triple Negative Breast Cancer Anaplastic Thyroid Carcinoma and Cutaneous Squamous Cell Carcinoma

Recruiting

18 years - 99 years

All

Phase 1

30 participants needed

1 Location

Brief description of study

Consider this study if you have cancer that is considered advanced and/or has spread to other parts of your body. You have received treatment for your cancer but your cancer has come back or has worsened following that treatment. As part of this study, you will complete routine procedures that you would typically receive as part of your typical standard of care treatment. These procedures will monitor your health and safety while taking part of the trial. You will also complete additional research procedures including: additional blood draws and a tumor biopsy.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Cutaneous Squamous Cell Carcinoma,Thyroid Carcinoma,Triple Negative Breast Cancer,Triple Negative Breast Cancer
Age: 18 years - 99 years
Gender: All

Male or Female, Age greater than 18, Cutaneous Squamous Cell Carcinoma, Thyroid Carcinoma ,Triple Negative Breast Cancer ,Triple Negative Breast Cancer

Updated on 04 Aug 2024. Study ID: 843918

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

A Study of CDK-002 (exoSTING) in Subjects with Advanced/Metastatic Recurrent Injectable Solid Tumors with Emphasis on Squamous Cell Carcinoma of the Head and Neck Triple Negative Breast Cancer Anaplastic Thyroid Carcinoma and Cutaneous Squamous Cell Carcinoma

Brief description of study

Eligibility of study

Find a site

Interested in the study